Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells

Blood

Volumn 87, Issue 1, 1996, Pages 93-101

  Hashiyama, Motohiro ^b   Iwama, Atsushi ^b   Ohshiro, Kazuiku ^b   Kurozumi, Kouichi ^b   Yasunaga, Kunio ^b   Shimizu, Yasuaki ^b   Masuho, Yasuhiko ^b   Matsuda, Ichiro ^b   Yamaguchi, Naoto ^b   Suda, Toshio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; EPIDERMAL GROWTH FACTOR; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOPOIESIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; UMBILICAL VEIN;

EID: 13344259324     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.93.bloodjournal87193     Document Type: Article

References (30)

1. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER: The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665, 1985
2. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A: The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88, 1988
3. Yarden Y, Kuang WJ, Yang FT, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341, 1987
4. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143, 1991
5. Partanen J, Armstrong E, Makela T, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K: A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12:1698, 1992
6. Iwama A, Hamaguchi I, Hashiyama M, Murayama Y, Yasunaga K, Suda T: Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun 195:301, 1993
7. Dumont DJ, Gradwohl GJ, Fong GH, Auerbach R, Breitman ML: The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene 8:1293, 1993
8. Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K: Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80:2548, 1992
9. Dumont DJ, Gradwohl G, Fong G-H, Puri MC, Gertsenstein M, Auerbach A, Breitman ML: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897, 1994
10. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70, 1995
11. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y, Suda T, Miura Y: Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 51:341, 1991
12. Sato T, Fuse A, Eguchi M, Hayashi Y, Sugita K, Nakazawa S, Minato K, Shima Y, Komori I, Sunami S, Okimoto Y, Nakajima H: Establishment and characterization of a megakaryoblastic cell line (CMK) from a Down's syndrome patient with acute megakaryoblastic leukemia. Br J Haematol 72:184, 1989
13. Tamura S, Sugawara M, Tanaka H, Tezuka E, Hihira S-I, Miyamoto C, Suda T, Ohta Y: A new hematopoietic cell line, KMT-2, having human interleukin-3 receptors. Blood 76:501, 1990
14. Komatsu N, Yamamoto M, Fujita H, Miwa A, Hatake K, Endo T, Okano H, Katsube T, Fukumaki Y, Sassa S: Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood 82:456, 1993
15. Sambrook J, Fritsch E, Maniatis T: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Press, 1989
16. Belyavsky A, Vinogradova T, Rajewsky K: PCR-based cDNA library construction: General cDNA libraries at the level of a few cells. Nucleic Acids Res 17:2919, 1989
17. Ema H, Suda T, Miura Y, Nakauchi H: Colony formation of clone-sorted human hematopoietic progenitors. Blood 75:1941, 1990
18. Ema H, Suda T, Nagayoshi K, Miura Y, Civin C, Nakauchi H: Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils. Blood 76:2483, 1990
19. Iscove NN, Sieber F, Winterhalter K: Erythroid colony formation in cultures of mouse and human bone marrow. Analysis of the requirement of erythropoietin by gel filtration and affinity chromatography on agarose - concanavalin A. J Cell Physiol 83:309, 1974
20. Dexter T, Moore M, Sheridan A: Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semi-allogeneic bone marrow chimeras in vitro. J Exp Med 145:1612, 1977
21. Verfaillie C, Blakolmer K, McGlave P: Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 172:509, 1990
22. Korhonen J, Polvi A, Partanen J, Alitalo K: The mouse tie receptor tyrosine kinase gene: Expression during embryonic angiogenesis. Oncogene 9:395, 1994
23. Armstrong E, Korhonen J, Silvernnoinen O, Cleveland JL, Lieberman MA, Alitalo R: Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia 7:1585, 1993
24. Rosnet O, Stephenson D, Mattei MG, Marchetto S, Shibuya M, Chapman VM, Birnbaum D: Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 8:173, 1993
25. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5:519, 1990
26. Park JE, Chen HH, Winer J, Houck KA, Ferrara N: Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646, 1994
27. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989, 1992
28. Millauer B, Wizigmann VS, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835, 1993
29. - progenitor cells. Blood 77:1218, 1991
30. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemishka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995